Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase.
about
Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Marked regression of myelofibr ...... leukemia in accelerated phase.
@en
Marked regression of myelofibr ...... leukemia in accelerated phase.
@nl
type
label
Marked regression of myelofibr ...... leukemia in accelerated phase.
@en
Marked regression of myelofibr ...... leukemia in accelerated phase.
@nl
prefLabel
Marked regression of myelofibr ...... leukemia in accelerated phase.
@en
Marked regression of myelofibr ...... leukemia in accelerated phase.
@nl
P2093
P2860
P1433
P1476
Marked regression of myelofibr ...... leukemia in accelerated phase.
@en
P2093
Elisabeth Huber
Martin Vogelhuber
Roland Christian Schelker
Wolfgang Herr
P2860
P304
P356
10.3109/10428194.2015.1045899
P577
2015-07-21T00:00:00Z